Action Packet - Professions and Public Health Subcommittee (March 9, 2021)

Summary

Action packet of the Professions and Public Health Subcommittee for Tuesday, March 9, 2021, starting 9:30 AM at Webster Hall (212 Knott), with Will Robinson listed as Chair. The meeting report concerns HB 1455 (Regulation of Medical Marijuana) and records Amendment 195759, Amendment 416833, Amendment 786337, Amendment 862937 and Amendment 901715 as Failed to Adopt. It also notes that an amendment to the amendment barcode 596769 was adopted without objection. The appearance listings for HB 1455 include Jodi James of Florida CAN|Florida Cannabis Action Network, Ronald Watson of ALTMed LLC and Jeffrey Sharkey of the Medical Marijuana Business Association of Florida, Inc, each listed as an opponent, and the last page is a lobbyist appearance form for that association.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“Action Packet - Professions and Public Health Subcommittee (March 9, 2021).” Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/2021-03-09-3093-professions-public-health-subcommittee-action-packets-bdf6976e5e/, SHA-256 212d3ec015e99b4c64843f6c8b0c4d4f14a5df1179cf2f1430d19b9d4ab00d5d.

Full text

Professions and Public Health
Subcommittee
Tuesday, March 9, 2021
9:30 AM – 11:30 PM
Webster Hall (212 Knott)

Action Packet

Chris Sprowls Will Robinson
Speaker Chair
COMMITTEE MEETING REPORT
Professions & Public Health Subcommittee
3/9/2021 9:30AM
Location: Webster Hall (212 Knott)

Summary:
Professions & Public Health Subcommittee

Tuesday March 09, 2021 09:30 am

Amendment 195759 Failed to Adopt

Amendment 416833 Failed to Adopt

Amendment 786337 Failed to Adopt

Amendment 862937 Failed to Adopt

Amendment 901715 Failed to Adopt
Amendment to the amendment barcode 596769 was adopted
without objection

Print Date: 03/09/2021 04:57 pm Leagis ® Page 1 of 6
COMMITTEE MEETING REPORT
Professions & Public Health Subcommittee
3/9/2021 9:30AM
Location: Webster Hall (212 Knott)

Attendance:

Present Absent Excused

William Robinson (Chair) X
Robert Andrade X
Kristen Arrington X
Anna Eskamani X
Juan Fernandez-Barquin X
Sam Garrison X
Michael Gottlieb X
Sam Killebrew X
Randall Maggard X
Patt Maney X
Stan McClain X
Michele Rayner X
Alex Rizo X
Bob Rommel X
Tyler Sirois X
Kelly Skidmore X
Carlos Smith X
Kaylee Tuck X

Totals: 18 0 0

Print Date: 03/09/2021 04:57 pm Leagis ® Page 2 of 6
COMMITTEE MEETING REPORT
Professions & Public Health Subcommittee
3/9/2021 9:30AM
Location: Webster Hall (212 Knott)
HB 1455 : Regulation of Medical Marijuana

HB 1455 Amendments

Amendment 195759

X Failed to Adopt

Amendment 416833

X Failed to Adopt

Amendment 786337

X Failed to Adopt

Amendment 862937

X Failed to Adopt

Amendment 901715 - Amendment to the amendment barcode 596769 was adopted without objection

X Failed to Adopt

Appearances:

Amendment 786337
James, Jodi (General Public) - Proponent
Florida CAN|Florida Cannabis Action Network
1375 Cypress Ave
Melbourne FL 32935
Phone: 3218907302

James, Jodi (General Public) - Opponent
Florida CAN|Florida Cannabis Action Network
1375 Cypress Ave
Melbourne FL 32935
Phone: 3218907302

Watson, Ronald (Lobbyist) (Lobbyist Appearance Form Submitted) - Opponent
ALTMed LLC
3738 Mundon Way
Tallahassee FL
Phone: (850) 567-1202

Print Date: 03/09/2021 04:57 pm Leagis ® Page 3 of 6
COMMITTEE MEETING REPORT
Professions & Public Health Subcommittee
3/9/2021 9:30AM
Location: Webster Hall (212 Knott)

Appearances: (continued)

Noe, Dr. Sasha (General Public) - Opponent
Self
7641 Nottinghill sky dr.
Apollo beach Fl 33572
Phone: 8133632592

Beasley, Dr. Michelle (General Public) - Opponent
Self
2 bayou Blvd
Pensacola Fl 32503
Phone: +1 (850) 393-1937

Hardwick, Sean (General Public) - Opponent
Regulatory Analyst
500 Chapel Dr #144
Tallahassee FL 32304
Phone: 7745268584

Stevens, Eric (General Public) - Opponent
Florida for Care
6900 Bay Dr. 9A
Miami Beach FL 33141
Phone: 5089422602

Sharkey, Jeffrey (Lobbyist) (Lobbyist Appearance Form Submitted) - Opponent
Medical Marijuana Business Association of Florida, Inc
President, Medical Marijuana Business Association of Florida
106 E. College Ave Ste 1110
TALLAHASSEE FL
Phone: (850) 224-1660 x___

Gordon, MD, Barry (General Public) - Opponent
My patients
Chief Medical Officer, Compassionate Cannabis Clinic
711 Fringed Orchid Trail
Venice Florida 34293
Phone: 216-973-7788

Goodson, John (General Public) - Opponent
Buds for vets
Mr
10 Guinevere lane Unit C
Crawfordville Florida 32327
Phone: 8505670169

Roundtree, Robert (General Public) - Opponent
Sunshine Cannabis
3324 nw 54th ter
Gainesville Fl 32606

Print Date: 03/09/2021 04:57 pm Leagis ® Page 4 of 6
COMMITTEE MEETING REPORT
Professions & Public Health Subcommittee
3/9/2021 9:30AM
Location: Webster Hall (212 Knott)

Appearances: (continued)

Amendment 416833
Goodson, John (General Public) - Proponent
Buds for vets
Mr
10 Guinevere lane Unit C
Crawfordville Florida 32327
Phone: 8505670169

Amendment 416833
Gordon, MD, Barry (General Public) - Proponent
My patients
Chief Medical Officer, Compassionate Cannabis Clinic
711 Fringed Orchid Trail
Venice Florida 34293
Phone: 216-973-7788

Amendment 416833
Noe, Dr. Sasha (General Public) - Proponent
Self
7641 Nottinghill sky dr.
Apollo beach Fl 33572
Phone: 8133632592

Amendment 416833
Beasley, Dr. Michelle (General Public) - Proponent
Self
2 bayou Blvd
Pensacola Fl 32503
Phone: +1 (850) 393-1937

Amendment 195759
Gordon, MD, Barry (General Public) - Proponent
My patients
Chief Medical Officer, Compassionate Cannabis Clinic
711 Fringed Orchid Trail
Venice Florida 34293
Phone: 216-973-7788

Amendment 195759
Goodson, John (General Public) - Proponent
Buds for vets
Mr
10 Guinevere lane Unit C
Crawfordville Florida 32327
Phone: 8505670169

Print Date: 03/09/2021 04:57 pm Leagis ® Page 5 of 6
COMMITTEE MEETING REPORT
Professions & Public Health Subcommittee
3/9/2021 9:30AM
Location: Webster Hall (212 Knott)

Appearances: (continued)

Amendment 862937
Gordon, MD, Barry (General Public) - Proponent
My patients
Chief Medical Officer, Compassionate Cannabis Clinic
711 Fringed Orchid Trail
Venice Florida 34293
Phone: 216-973-7788

Amendment 901715
James, Jodi (General Public) - Proponent
Florida CAN|Florida Cannabis Action Network
1375 Cypress Ave
Melbourne FL 32935
Phone: 3218907302

Amendment 901715
Noe, Dr. Sasha (General Public) - Proponent
Self
7641 Nottinghill sky dr.
Apollo beach Fl 33572
Phone: 8133632592

Amendment 901715
Beasley, Dr. Michelle (General Public) - Proponent
Self
2 bayou Blvd
Pensacola Fl 32503
Phone: +1 (850) 393-1937

Amendment 901715
Goodson, John (General Public) - Proponent
Buds for vets
Mr
10 Guinevere lane Unit C
Crawfordville Florida 32327
Phone: 8505670169

Watson, Ronald (Lobbyist) - Opponent
ALTMed LLC
3738 Mundon Way
Tallahassee FL 32309
Phone: (850) 567-1202

Print Date: 03/09/2021 04:57 pm Leagis ® Page 6 of 6
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 1

COMMITTEE/SUBCOMMITTEE ACTION
ADOPTED (Y/N)
ADOPTED AS AMENDED (Y/N)
ADOPTED W/O OBJECTION (Y/N)
FAILED TO ADOPT Y (Y/N)
WITHDRAWN (Y/N)
OTHER

1 Committee/Subcommittee hearing bill: Professions & Public
2 Health Subcommittee
3 Representative Eskamani offered the following:
4
5 Amendment (with directory and title amendments)
6 Between lines 107 and 108, insert:
7 (7) IDENTIFICATION CARDS.—
8 (a) The department shall issue medical marijuana use
9 registry identification cards for qualified patients and
10 caregivers who are residents of this state, which must be
11 renewed every 2 years annually. The identification cards must be
12 resistant to counterfeiting and tampering and must include, at a
13 minimum, the following:
14 1. The name, address, and date of birth of the qualified
15 patient or caregiver.
16 2. A full-face, passport-type, color photograph of the
786337 - h1455-line107.docx
Published On: 3/8/2021 7:10:05 PM
Page 1 of 2
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 1

17 qualified patient or caregiver taken within the 90 days
18 immediately preceding registration or the Florida driver license
19 or Florida identification card photograph of the qualified
20 patient or caregiver obtained directly from the Department of
21 Highway Safety and Motor Vehicles.
22 3. Identification as a qualified patient or a caregiver.
23 4. The unique numeric identifier used for the qualified
24 patient in the medical marijuana use registry.
25 5. For a caregiver, the name and unique numeric identifier
26 of the caregiver and the qualified patient or patients that the
27 caregiver is assisting.
28 6. The expiration date of the identification card.
29
30 -----------------------------------------------------
31 D I R E C T O R Y A M E N D M E N T
32 Remove line 55 and insert:
33 subsection (3), paragraph (a) of subsection (7), and paragraphs
34 (e) and (h) of subsection (8) are
35
36 -----------------------------------------------------
37 T I T L E A M E N D M E N T
38 Remove line 7 and insert:
39 exceptions; revising the frequency with which medical
40 marijuana use registry identification cards must be
41 renewed; prohibiting medical marijuana treatment
786337 - h1455-line107.docx
Published On: 3/8/2021 7:10:05 PM
Page 2 of 2
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 2

COMMITTEE/SUBCOMMITTEE ACTION
ADOPTED (Y/N)
ADOPTED AS AMENDED (Y/N)
ADOPTED W/O OBJECTION (Y/N)
FAILED TO ADOPT Y (Y/N)
WITHDRAWN (Y/N)
OTHER

1 Committee/Subcommittee hearing bill: Professions & Public
2 Health Subcommittee
3 Representative Rayner offered the following:
4
5 Amendment (with directory and title amendments)
6 Between lines 107 and 108, insert:
7 (4) PHYSICIAN CERTIFICATION.—
8 (a) A qualified physician may issue a physician
9 certification only if the qualified physician:
10 1. Conducted a physical examination for the initial
11 patient visit while physically present in the same room as the
12 patient and a full assessment of the medical history of the
13 patient. Telehealth may be used to issue a physician
14 certification for an existing qualified patient with an existing
15 certification that was issued by that qualified physician

416833 - h1455-line107(Rayner).docx
Published On: 3/8/2021 7:54:17 PM
Page 1 of 5
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 2

16 without the need to conduct a physical examination while
17 physically present in the same room as the patient.
18 2. Diagnosed the patient with at least one qualifying
19 medical condition.
20 3. Determined that the medical use of marijuana would
21 likely outweigh the potential health risks for the patient, and
22 such determination must be documented in the patient's medical
23 record. If a patient is younger than 18 years of age, a second
24 physician must concur with this determination, and such
25 concurrence must be documented in the patient's medical record.
26 4. Determined whether the patient is pregnant and
27 documented such determination in the patient's medical record. A
28 physician may not issue a physician certification, except for
29 low-THC cannabis, to a patient who is pregnant.
30 5. Reviewed the patient's controlled drug prescription
31 history in the prescription drug monitoring program database
32 established pursuant to s. 893.055.
33 6. Reviews the medical marijuana use registry and
34 confirmed that the patient does not have an active physician
35 certification from another qualified physician.
36 7. Registers as the issuer of the physician certification
37 for the named qualified patient on the medical marijuana use
38 registry in an electronic manner determined by the department,
39 and:

416833 - h1455-line107(Rayner).docx
Published On: 3/8/2021 7:54:17 PM
Page 2 of 5
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 2

40 a. Enters into the registry the contents of the physician
41 certification, including the patient's qualifying condition and
42 the dosage not to exceed the daily dose amount determined by the
43 department, the amount and forms of marijuana authorized for the
44 patient, and any types of marijuana delivery devices needed by
45 the patient for the medical use of marijuana.
46 b. Updates the registry within 7 days after any change is
47 made to the original physician certification to reflect such
48 change.
49 c. Deactivates the registration of the qualified patient
50 and the patient's caregiver when the physician no longer
51 recommends the medical use of marijuana for the patient.
52 8. Obtains the voluntary and informed written consent of
53 the patient for medical use of marijuana each time the qualified
54 physician issues a physician certification for the patient,
55 which shall be maintained in the patient's medical record. The
56 patient, or the patient's parent or legal guardian if the
57 patient is a minor, must sign the informed consent acknowledging
58 that the qualified physician has sufficiently explained its
59 content. The qualified physician must use a standardized
60 informed consent form adopted in rule by the Board of Medicine
61 and the Board of Osteopathic Medicine, which must include, at a
62 minimum, information related to:
63 a. The Federal Government's classification of marijuana as
64 a Schedule I controlled substance.
416833 - h1455-line107(Rayner).docx
Published On: 3/8/2021 7:54:17 PM
Page 3 of 5
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 2

65 b. The approval and oversight status of marijuana by the
66 Food and Drug Administration.
67 c. The current state of research on the efficacy of
68 marijuana to treat the qualifying conditions set forth in this
69 section.
70 d. The potential for addiction.
71 e. The potential effect that marijuana may have on a
72 patient's coordination, motor skills, and cognition, including a
73 warning against operating heavy machinery, operating a motor
74 vehicle, or engaging in activities that require a person to be
75 alert or respond quickly.
76 f. The potential side effects of marijuana use, including
77 the negative health risks associated with smoking marijuana.
78 g. The risks, benefits, and drug interactions of
79 marijuana.
80 h. That the patient's de-identified health information
81 contained in the physician certification and medical marijuana
82 use registry may be used for research purposes.
83
84 -----------------------------------------------------
85 D I R E C T O R Y A M E N D M E N T
86 Remove line 55 and insert:
87 subsection (3), paragraph (a) of subsection (4), and paragraphs
88 (e) and (h) of subsection (8) are
89
416833 - h1455-line107(Rayner).docx
Published On: 3/8/2021 7:54:17 PM
Page 4 of 5
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 2

90 -----------------------------------------------------
91 T I T L E A M E N D M E N T
92 Remove line 4 and insert:
93 definition; revising and providing conditions for a
94 qualified physician to issue a physician
95 certification; prohibiting qualified physicians from

416833 - h1455-line107(Rayner).docx
Published On: 3/8/2021 7:54:17 PM
Page 5 of 5
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 3

COMMITTEE/SUBCOMMITTEE ACTION
ADOPTED (Y/N)
ADOPTED AS AMENDED (Y/N)
ADOPTED W/O OBJECTION (Y/N)
FAILED TO ADOPT Y (Y/N)
WITHDRAWN (Y/N)
OTHER

1 Committee/Subcommittee hearing bill: Professions & Public
2 Health Subcommittee
3 Representative Eskamani offered the following:
4
5 Amendment (with directory and title amendments)
6 Between lines 457 and 458, insert:
7 (2) QUALIFYING MEDICAL CONDITIONS.—A patient must be
8 diagnosed with at least one of the following conditions to
9 qualify to receive marijuana or a marijuana delivery device:
10 (n) Addiction to or dependence on an opioid drug.
11
12 -----------------------------------------------------
13 D I R E C T O R Y A M E N D M E N T
14 Remove line 455 and insert:
15 amended, and a new paragraph (n) is added to subsection (2) and
16 a new paragraph (g) is added to subsection (4) of
195759 - h1455-line457.docx
Published On: 3/8/2021 7:12:35 PM
Page 1 of 2
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 3

17
18 -----------------------------------------------------
19 T I T L E A M E N D M E N T
20 Remove line 3 and insert:
21 marijuana; amending s. 381.986, F.S.; providing that
22 addiction to or dependence on an opioid drug is a
23 qualifying condition to receive marijuana or a
24 marijuana delivery device; providing a

195759 - h1455-line457.docx
Published On: 3/8/2021 7:12:35 PM
Page 2 of 2
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 4

COMMITTEE/SUBCOMMITTEE ACTION
ADOPTED (Y/N)
ADOPTED AS AMENDED (Y/N)
ADOPTED W/O OBJECTION (Y/N)
FAILED TO ADOPT Y (Y/N)
WITHDRAWN (Y/N)
OTHER

1 Committee/Subcommittee hearing bill: Professions & Public
2 Health Subcommittee
3 Representative Rayner offered the following:
4
5 Amendment (with directory and title amendments)
6 Between lines 457 and 458, insert:
7 (2) QUALIFYING MEDICAL CONDITIONS.—A patient must be
8 diagnosed with at least one of the following conditions to
9 qualify to receive marijuana or a marijuana delivery device:
10 (n) Sickle cell disease.
11
12 -----------------------------------------------------
13 D I R E C T O R Y A M E N D M E N T
14 Remove line 455 and insert:
15 amended, and a new paragraph (n) is added to subsection (2) and
16 a new paragraph (g) is added to subsection (4) of
862937 - h1455-line457(Rayner).docx
Published On: 3/8/2021 9:00:37 PM
Page 1 of 2
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 4

17
18 -----------------------------------------------------
19 T I T L E A M E N D M E N T
20 Remove line 3 and insert:
21 marijuana; amending s. 381.986, F.S.; providing that
22 sickle cell disease is a qualifying condition to
23 receive marijuana or a marijuana delivery device;
24 providing a

862937 - h1455-line457(Rayner).docx
Published On: 3/8/2021 9:00:37 PM
Page 2 of 2
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

COMMITTEE/SUBCOMMITTEE ACTION
ADOPTED (Y/N)
ADOPTED AS AMENDED (Y/N)
ADOPTED W/O OBJECTION (Y/N)
FAILED TO ADOPT Y (Y/N)
WITHDRAWN (Y/N)
OTHER

1 Committee/Subcommittee hearing bill: Professions & Public
2 Health Subcommittee
3 Representative Smith, C. offered the following:
4
5 Amendment (with directory and title amendments)
6 Remove lines 528-908 and insert:
7 use registry may be used for research purposes. The Office of
8 Program Policy Analysis and Government Accountability shall
9 research the use of high concentrate THC, including any adverse
10 patient outcomes recorded as a result of the use of THC using
11 existing data from the medical marijuana use registry and
12 patients' de-identified health information. The office shall
13 report its findings to the Governor, the President of the
14 Senate, and the Speaker of the House of Representatives by
15 October 1, 2021.
16 (d) A qualified physician may not issue a physician
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 1 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

17 certification to a patient under 18 years of age for marijuana,
18 except for low-THC cannabis, unless the qualified physician
19 determines that marijuana other than low-THC cannabis is the
20 most effective treatment for the patient and a second physician
21 who is a board-certified pediatrician concurs with such
22 determination. A qualified physician may not issue a physician
23 certification for marijuana in a form for smoking to a patient
24 under 18 years of age unless the patient is diagnosed with a
25 terminal condition, the qualified physician determines that
26 smoking is the most effective route of administration for the
27 patient, and a second physician who is a board-certified
28 pediatrician concurs with such determination. Such
29 determinations determination and concurrences concurrence must
30 be documented in the patient's medical record and in the medical
31 marijuana use registry. The certifying physician must obtain the
32 written informed consent of such patient's parent or legal
33 guardian before issuing a physician certification to the patient
34 for marijuana or marijuana in a form for smoking. The qualified
35 physician must use a standardized informed consent form adopted
36 in rule by the Board of Medicine and the Board of Osteopathic
37 Medicine which must include information concerning the negative
38 health effects of marijuana and smoking marijuana on persons
39 under 18 years of age and an acknowledgment that the qualified
40 physician has sufficiently explained the contents of the form.
41 (f) A qualified physician may not issue a physician
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 2 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

42 certification for more than three 70-day supply limits of
43 marijuana or more than six 35-day supply limits of marijuana in
44 a form for smoking. The department may shall quantify by rule a
45 daily dose amount with equivalent dose amounts for each
46 allowable form of marijuana dispensed by a medical marijuana
47 treatment center. A 35-day supply of marijuana may not exceed
48 54,250 milligrams of tetrahydrocannabinol The department shall
49 use the daily dose amount to calculate a 70-day supply.
50 1. A qualified physician may request an exception to the
51 daily dose amount limit, the 35-day supply limit of marijuana in
52 a form for smoking, and the 4-ounce possession limit of
53 marijuana in a form for smoking established in paragraph
54 (14)(a). The request shall be made electronically on a form
55 adopted by the department in rule and must include, at a
56 minimum:
57 a. The qualified patient's qualifying medical condition.
58 b. The dosage and route of administration that was
59 insufficient to provide relief to the qualified patient.
60 c. A description of how the patient will benefit from an
61 increased amount.
62 d. The minimum daily dose amount of marijuana that would
63 be sufficient for the treatment of the qualified patient's
64 qualifying medical condition.
65 2. A qualified physician must provide the qualified
66 patient's records upon the request of the department.
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 3 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

67 3. The department shall approve or disapprove the request
68 within 14 days after receipt of the complete documentation
69 required by this paragraph. The request shall be deemed approved
70 if the department fails to act within this time period.
71 (8) MEDICAL MARIJUANA TREATMENT CENTERS.—
72 (e) A licensed medical marijuana treatment center shall
73 cultivate, process, transport, and dispense marijuana for
74 medical use. A licensed medical marijuana treatment center may
75 not contract for services directly related to the cultivation,
76 processing, and dispensing of marijuana or marijuana delivery
77 devices, except that a medical marijuana treatment center
78 licensed pursuant to subparagraph (a)1. may contract with a
79 single entity for the cultivation, processing, transporting, and
80 dispensing of marijuana and marijuana delivery devices. A
81 licensed medical marijuana treatment center must, at all times,
82 maintain compliance with the criteria demonstrated and
83 representations made in the initial application and the criteria
84 established in this subsection. Upon request, the department may
85 grant a medical marijuana treatment center a variance from the
86 representations made in the initial application. Consideration
87 of such a request shall be based upon the individual facts and
88 circumstances surrounding the request. A variance may not be
89 granted unless the requesting medical marijuana treatment center
90 can demonstrate to the department that it has a proposed
91 alternative to the specific representation made in its
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 4 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

92 application which fulfills the same or a similar purpose as the
93 specific representation in a way that the department can
94 reasonably determine will not be a lower standard than the
95 specific representation in the application. A variance may not
96 be granted from the requirements in subparagraph 2. and
97 subparagraphs (b)1. and 2.
98 1. A licensed medical marijuana treatment center may
99 transfer ownership to an individual or entity who meets the
100 requirements of this section. A publicly traded corporation or
101 publicly traded company that meets the requirements of this
102 section is not precluded from ownership of a medical marijuana
103 treatment center. To accommodate a change in ownership:
104 a. The licensed medical marijuana treatment center shall
105 notify the department in writing at least 60 days before the
106 anticipated date of the change of ownership.
107 b. The individual or entity applying for initial licensure
108 due to a change of ownership must submit an application that
109 must be received by the department at least 60 days before the
110 date of change of ownership.
111 c. Upon receipt of an application for a license, the
112 department shall examine the application and, within 30 days
113 after receipt, notify the applicant in writing of any apparent
114 errors or omissions and request any additional information
115 required.
116 d. Requested information omitted from an application for
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 5 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

117 licensure must be filed with the department within 21 days after
118 the department's request for omitted information or the
119 application shall be deemed incomplete and shall be withdrawn
120 from further consideration and the fees shall be forfeited.
121
122 Within 30 days after the receipt of a complete application, the
123 department shall approve or deny the application.
124 2. A medical marijuana treatment center, and any
125 individual or entity who directly or indirectly owns, controls,
126 or holds with power to vote 5 percent or more of the voting
127 shares of a medical marijuana treatment center, may not acquire
128 direct or indirect ownership or control of any voting shares or
129 other form of ownership of any other medical marijuana treatment
130 center.
131 3. A medical marijuana treatment center and any individual
132 or entity that directly or indirectly owns, controls, or holds
133 with power to vote 5 percent or more of the voting shares of a
134 medical marijuana treatment center may not employ a qualified
135 physician or have any direct or indirect economic interest in a
136 qualified physician's practice or a marijuana testing
137 laboratory.
138 4. A medical marijuana treatment center may not enter into
139 any form of profit-sharing arrangement with the property owner
140 or lessor of any of its facilities where cultivation,
141 processing, storing, or dispensing of marijuana and marijuana
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 6 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

142 delivery devices occurs.
143 5. All employees of a medical marijuana treatment center
144 must be 21 years of age or older and have passed a background
145 screening pursuant to subsection (9).
146 6. Each medical marijuana treatment center must adopt and
147 enforce policies and procedures to ensure employees and
148 volunteers receive training on the legal requirements to
149 dispense marijuana to qualified patients.
150 7. When growing marijuana, a medical marijuana treatment
151 center:
152 a. May use pesticides determined by the department, after
153 consultation with the Department of Agriculture and Consumer
154 Services, to be safely applied to plants intended for human
155 consumption, but may not use pesticides designated as
156 restricted-use pesticides pursuant to s. 487.042.
157 b. Must grow marijuana within an enclosed structure and in
158 a room separate from any other plant.
159 c. Must inspect seeds and growing plants for plant pests
160 that endanger or threaten the horticultural and agricultural
161 interests of the state in accordance with chapter 581 and any
162 rules adopted thereunder.
163 d. Must perform fumigation or treatment of plants, or
164 remove and destroy infested or infected plants, in accordance
165 with chapter 581 and any rules adopted thereunder.
166 8. Each medical marijuana treatment center must produce
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 7 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

167 and make available for purchase at least one low-THC cannabis
168 product.
169 9. A medical marijuana treatment center that produces
170 edibles must hold a permit to operate as a food establishment
171 pursuant to chapter 500, the Florida Food Safety Act, and must
172 comply with all the requirements for food establishments
173 pursuant to chapter 500 and any rules adopted thereunder.
174 Edibles may not contain more than 200 milligrams of
175 tetrahydrocannabinol, and a single serving portion of an edible
176 may not exceed 10 milligrams of tetrahydrocannabinol. Edibles
177 may have a potency variance of no greater than 15 percent of the
178 10 milligrams of tetrahydrocannabinol per single serving limit
179 or 15 percent of the 200 milligrams of tetrahydrocannabinol per
180 product limit. Edibles may not be attractive to children; be
181 manufactured in the shape of humans, cartoons, or animals; be
182 manufactured in a form that bears any reasonable resemblance to
183 products available for consumption as commercially available
184 candy; or contain any color additives. To discourage consumption
185 of edibles by children, the department shall determine by rule
186 any shapes, forms, and ingredients allowed and prohibited for
187 edibles. Medical marijuana treatment centers may not begin
188 processing or dispensing edibles until after the effective date
189 of the rule. The department shall also adopt sanitation rules
190 providing the standards and requirements for the storage,
191 display, or dispensing of edibles.
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 8 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

192 10. Within 12 months after licensure, a medical marijuana
193 treatment center must demonstrate to the department that all of
194 its processing facilities have passed a Food Safety Good
195 Manufacturing Practices, such as Global Food Safety Initiative
196 or equivalent, inspection by a nationally accredited certifying
197 body. A medical marijuana treatment center must immediately stop
198 processing at any facility which fails to pass this inspection
199 until it demonstrates to the department that such facility has
200 met this requirement.
201 11. A medical marijuana treatment center that produces
202 prerolled marijuana cigarettes may not use wrapping paper made
203 with tobacco or hemp.
204 12. When processing marijuana, a medical marijuana
205 treatment center must:
206 a. Process the marijuana within an enclosed structure and
207 in a room separate from other plants or products.
208 b. Comply with department rules when processing marijuana
209 with hydrocarbon solvents or other solvents or gases exhibiting
210 potential toxicity to humans. The department shall determine by
211 rule the requirements for medical marijuana treatment centers to
212 use such solvents or gases exhibiting potential toxicity to
213 humans.
214 c. Comply with federal and state laws and regulations and
215 department rules for solid and liquid wastes. The department
216 shall determine by rule procedures for the storage, handling,
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 9 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

217 transportation, management, and disposal of solid and liquid
218 waste generated during marijuana production and processing. The
219 Department of Environmental Protection shall assist the
220 department in developing such rules.
221 13. A medical marijuana treatment center must test
222 marijuana using a medical marijuana testing laboratory before it
223 is dispensed. Results must be verified and signed by two medical
224 marijuana treatment center employees. Before dispensing, the
225 medical marijuana treatment center must determine that the test
226 results indicate that low-THC cannabis meets the definition of
227 low-THC cannabis, the concentration of tetrahydrocannabinol
228 meets the potency requirements of this section, the labeling of
229 the concentration of tetrahydrocannabinol and cannabidiol is
230 accurate, and all marijuana is safe for human consumption and
231 free from contaminants that are unsafe for human consumption.
232 The department shall determine by rule which contaminants must
233 be tested for and the maximum levels of each contaminant which
234 are safe for human consumption. The Department of Agriculture
235 and Consumer Services shall assist the department in developing
236 the testing requirements for contaminants that are unsafe for
237 human consumption in edibles. The department shall also
238 determine by rule the procedures for the treatment of marijuana
239 that fails to meet the testing requirements of this section, s.
240 381.988, or department rule. The department may select samples
241 of marijuana available in a cultivation facility, processing
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 10 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

242 facility, or for purchase in a dispensing facility which shall
243 be tested by the department to determine that the marijuana
244 meets the potency requirements of this section, is safe for
245 human consumption, and the labeling of the tetrahydrocannabinol
246 and cannabidiol concentration is accurate or to verify medical
247 marijuana testing laboratory results. The department may also
248 sample marijuana delivery devices from a dispensing facility to
249 determine that the marijuana delivery device is safe for use by
250 qualified patients. A medical marijuana treatment center may not
251 require payment from the department for the sample. A medical
252 marijuana treatment center must recall all marijuana which fails
253 to meet the potency requirements of this section, which is
254 unsafe for human consumption, or for which the labeling of the
255 tetrahydrocannabinol and cannabidiol concentration is
256 inaccurate. The medical marijuana treatment center must retain
257 records of all testing and samples of each homogenous batch of
258 marijuana for at least 9 months. The medical marijuana treatment
259 center must contract with a marijuana testing laboratory to
260 perform audits on the medical marijuana treatment center's
261 standard operating procedures, testing records, and samples and
262 provide the results to the department to confirm that the
263 marijuana or low-THC cannabis meets the requirements of this
264 section and that the marijuana or low-THC cannabis is safe for
265 human consumption. A medical marijuana treatment center shall
266 reserve two processed samples from each batch and retain such
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 11 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

267 samples for at least 9 months for the purpose of such audits. A
268 medical marijuana treatment center may use a laboratory that has
269 not been certified by the department under s. 381.988 until such
270 time as at least one laboratory holds the required
271 certification, but in no event later than July 1, 2018.
272 14. When packaging marijuana, a medical marijuana
273 treatment center must:
274 a. Package the marijuana in compliance with the United
275 States Poison Prevention Packaging Act of 1970, 15 U.S.C. ss.
276 1471 et seq.
277 b. Package the marijuana in a receptacle that has a firmly
278 affixed and legible label stating the following information:
279 (I) The marijuana or low-THC cannabis meets the
280 requirements of subparagraph 13.
281 (II) The name of the medical marijuana treatment center
282 from which the marijuana originates.
283 (III) The batch number and harvest number from which the
284 marijuana originates and the date dispensed.
285 (IV) The name of the physician who issued the physician
286 certification.
287 (V) The name of the patient.
288 (VI) The product name, if applicable, and dosage form,
289 including concentration of tetrahydrocannabinol and cannabidiol.
290 The product name may not contain wording commonly associated
291 with products marketed by or to children.
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 12 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

292 (VII) The recommended dose.
293 (VIII) A warning that it is illegal to transfer medical
294 marijuana to another person.
295 (IX) A marijuana universal symbol developed by the
296 department.
297 15. The medical marijuana treatment center shall include
298 in each package a patient package insert with information on the
299 specific product dispensed related to:
300 a. Clinical pharmacology.
301 b. Indications and use.
302 c. Dosage and administration.
303 d. Dosage forms and strengths.
304 e. Contraindications.
305 f. Warnings and precautions.
306 g. Adverse reactions.
307 16. In addition to the packaging and labeling requirements
308 specified in subparagraphs 14. and 15., marijuana in a form for
309 smoking must be packaged in a sealed receptacle with a legible
310 and prominent warning to keep away from children and a warning
311 that states marijuana smoke contains carcinogens and may
312 negatively affect health. Such receptacles for marijuana in a
313 form for smoking must be plain, opaque, and white without
314 depictions of the product or images other than the medical
315 marijuana treatment center's department-approved logo and the
316 marijuana universal symbol.
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 13 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

317 17. The department shall adopt rules to regulate the
318 types, appearance, and labeling of marijuana delivery devices
319 dispensed from a medical marijuana treatment center. The rules
320 must require marijuana delivery devices to have an appearance
321 consistent with medical use.
322 18. Each edible shall be individually sealed in plain,
323 opaque wrapping marked only with the marijuana universal symbol.
324 Where practical, each edible shall be marked with the marijuana
325 universal symbol. In addition to the packaging and labeling
326 requirements in subparagraphs 14. and 15., edible receptacles
327 must be plain, opaque, and white without depictions of the
328 product or images other than the medical marijuana treatment
329 center's department-approved logo and the marijuana universal
330 symbol. The receptacle must also include a list of all the
331 edible's ingredients, storage instructions, an expiration date,
332 a legible and prominent warning to keep away from children and
333 pets, and a warning that the edible has not been produced or
334 inspected pursuant to federal food safety laws.
335 19. When dispensing marijuana or a marijuana delivery
336 device, a medical marijuana treatment center:
337 a. May dispense any active, valid order for low-THC
338 cannabis, medical cannabis and cannabis delivery devices issued
339 pursuant to former s. 381.986, Florida Statutes 2016, which was
340 entered into the medical marijuana use registry before July 1,
341 2017.
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 14 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

342 b. May not dispense more than two 35-day supplies a 70-day
343 supply of marijuana within any 70-day period to a qualified
344 patient or caregiver. May not dispense more than one 35-day
345 supply of marijuana in a form for smoking within any 35-day
346 period to a qualified patient or caregiver. A 35-day supply of
347 marijuana in a form for smoking may not exceed 54,250 milligrams
348 of tetrahydrocannabinol 2.5 ounces unless an exception to this
349 amount is approved by the department pursuant to paragraph
350 (4)(f).
351 c. Must have the medical marijuana treatment center's
352 employee who dispenses the marijuana or a marijuana delivery
353 device enter into the medical marijuana use registry his or her
354 name or unique employee identifier.
355 d. Must verify that the qualified patient and the
356 caregiver, if applicable, each have an active registration in
357 the medical marijuana use registry and an active and valid
358 medical marijuana use registry identification card, the amount
359 and type of marijuana dispensed matches the physician
360 certification in the medical marijuana use registry for that
361 qualified patient, and the physician certification has not
362 already been filled.
363 e. May not dispense marijuana to a qualified patient who
364 is younger than 18 years of age. If the qualified patient is
365 younger than 18 years of age, marijuana may only be dispensed to
366 the qualified patient's caregiver.
901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 15 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

367 f. May not dispense or sell any other type of cannabis,
368 alcohol, or illicit drug-related product, including pipes or
369 wrapping papers made with tobacco or hemp, other than a
370 marijuana delivery device required for the medical use of
371 marijuana and which is specified in a physician certification.
372 g. Must, upon dispensing the marijuana or marijuana
373 delivery device, record in the registry the date, time,
374 quantity, and form of marijuana dispensed; the type of marijuana
375 delivery device dispensed; and the name and medical marijuana
376 use registry identification number of the qualified patient or
377 caregiver to whom the marijuana delivery device was dispensed.
378 h. Must ensure that patient records are not visible to
379
380 -----------------------------------------------------
381 D I R E C T O R Y A M E N D M E N T
382 Remove lines 450-456 and insert:
383 Section 2. Effective July 1, 2022, paragraphs (a), (d),
384 and (f) of subsection (4), paragraph (e) of subsection (8), and
385 paragraph (a) of subsection (14) of s. 381.986, Florida
386 Statutes, are amended to read:
387
388 -----------------------------------------------------
389 T I T L E A M E N D M E N T
390 Remove lines 26-41 and insert:

901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 16 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 5

391 dispose of marijuana; requiring the Office of Program
392 Policy Analysis and Government Accountability to
393 research the use of high concentrate THC and report
394 its findings to the Governor and Legislature by a
395 specified date; prohibiting a qualified physician from
396 issuing a physician certification to a minor patient
397 for marijuana, except for low-THC cannabis; providing
398 an exception; revising the supply limits of marijuana
399 for which a physician certification may be issued;
400 limiting the potency of tetrahydrocannabinol in such
401 supply; prohibiting a medical marijuana treatment
402 center from dispensing a certain daily supply within a
403 specified period to conform to changes made by the
404 act; amending s. 381.988, F.S.; prohibiting a

901715 - h1455-line528.docx
Published On: 3/8/2021 7:16:20 PM
Page 17 of 17
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 6

COMMITTEE/SUBCOMMITTEE ACTION
ADOPTED (Y/N)
ADOPTED AS AMENDED (Y/N)
ADOPTED W/O OBJECTION Y (Y/N)
FAILED TO ADOPT (Y/N)
WITHDRAWN (Y/N)
OTHER

1 Committee/Subcommittee hearing bill: Professions & Public
2 Health Subcommittee
3 Representative Smith, C. offered the following:
4
5 Amendment to Amendment (901715) by Representative Smith, C.
6
7 Remove lines 48-347 of the amendment and insert:
8 35,000 milligrams of tetrahydrocannabinol The department shall
9 use the daily dose amount to calculate a 70-day supply.
10 1. A qualified physician may request an exception to the
11 daily dose amount limit, the 35-day supply limit of marijuana in
12 a form for smoking, and the 4-ounce possession limit of
13 marijuana in a form for smoking established in paragraph
14 (14)(a). The request shall be made electronically on a form
15 adopted by the department in rule and must include, at a
16 minimum:
596769 - h1455-line528 amendment to amendment.docx
Published On: 3/9/2021 3:55:43 PM
Page 1 of 13
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 6

17 a. The qualified patient's qualifying medical condition.
18 b. The dosage and route of administration that was
19 insufficient to provide relief to the qualified patient.
20 c. A description of how the patient will benefit from an
21 increased amount.
22 d. The minimum daily dose amount of marijuana that would
23 be sufficient for the treatment of the qualified patient's
24 qualifying medical condition.
25 2. A qualified physician must provide the qualified
26 patient's records upon the request of the department.
27 3. The department shall approve or disapprove the request
28 within 14 days after receipt of the complete documentation
29 required by this paragraph. The request shall be deemed approved
30 if the department fails to act within this time period.
31 (8) MEDICAL MARIJUANA TREATMENT CENTERS.—
32 (e) A licensed medical marijuana treatment center shall
33 cultivate, process, transport, and dispense marijuana for
34 medical use. A licensed medical marijuana treatment center may
35 not contract for services directly related to the cultivation,
36 processing, and dispensing of marijuana or marijuana delivery
37 devices, except that a medical marijuana treatment center
38 licensed pursuant to subparagraph (a)1. may contract with a
39 single entity for the cultivation, processing, transporting, and
40 dispensing of marijuana and marijuana delivery devices. A
41 licensed medical marijuana treatment center must, at all times,
596769 - h1455-line528 amendment to amendment.docx
Published On: 3/9/2021 3:55:43 PM
Page 2 of 13
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 6

42 maintain compliance with the criteria demonstrated and
43 representations made in the initial application and the criteria
44 established in this subsection. Upon request, the department may
45 grant a medical marijuana treatment center a variance from the
46 representations made in the initial application. Consideration
47 of such a request shall be based upon the individual facts and
48 circumstances surrounding the request. A variance may not be
49 granted unless the requesting medical marijuana treatment center
50 can demonstrate to the department that it has a proposed
51 alternative to the specific representation made in its
52 application which fulfills the same or a similar purpose as the
53 specific representation in a way that the department can
54 reasonably determine will not be a lower standard than the
55 specific representation in the application. A variance may not
56 be granted from the requirements in subparagraph 2. and
57 subparagraphs (b)1. and 2.
58 1. A licensed medical marijuana treatment center may
59 transfer ownership to an individual or entity who meets the
60 requirements of this section. A publicly traded corporation or
61 publicly traded company that meets the requirements of this
62 section is not precluded from ownership of a medical marijuana
63 treatment center. To accommodate a change in ownership:
64 a. The licensed medical marijuana treatment center shall
65 notify the department in writing at least 60 days before the
66 anticipated date of the change of ownership.
596769 - h1455-line528 amendment to amendment.docx
Published On: 3/9/2021 3:55:43 PM
Page 3 of 13
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 6

67 b. The individual or entity applying for initial licensure
68 due to a change of ownership must submit an application that
69 must be received by the department at least 60 days before the
70 date of change of ownership.
71 c. Upon receipt of an application for a license, the
72 department shall examine the application and, within 30 days
73 after receipt, notify the applicant in writing of any apparent
74 errors or omissions and request any additional information
75 required.
76 d. Requested information omitted from an application for
77 licensure must be filed with the department within 21 days after
78 the department's request for omitted information or the
79 application shall be deemed incomplete and shall be withdrawn
80 from further consideration and the fees shall be forfeited.
81
82 Within 30 days after the receipt of a complete application, the
83 department shall approve or deny the application.
84 2. A medical marijuana treatment center, and any
85 individual or entity who directly or indirectly owns, controls,
86 or holds with power to vote 5 percent or more of the voting
87 shares of a medical marijuana treatment center, may not acquire
88 direct or indirect ownership or control of any voting shares or
89 other form of ownership of any other medical marijuana treatment
90 center.
91 3. A medical marijuana treatment center and any individual
596769 - h1455-line528 amendment to amendment.docx
Published On: 3/9/2021 3:55:43 PM
Page 4 of 13
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 6

92 or entity that directly or indirectly owns, controls, or holds
93 with power to vote 5 percent or more of the voting shares of a
94 medical marijuana treatment center may not employ a qualified
95 physician or have any direct or indirect economic interest in a
96 qualified physician's practice or a marijuana testing
97 laboratory.
98 4. A medical marijuana treatment center may not enter into
99 any form of profit-sharing arrangement with the property owner
100 or lessor of any of its facilities where cultivation,
101 processing, storing, or dispensing of marijuana and marijuana
102 delivery devices occurs.
103 5. All employees of a medical marijuana treatment center
104 must be 21 years of age or older and have passed a background
105 screening pursuant to subsection (9).
106 6. Each medical marijuana treatment center must adopt and
107 enforce policies and procedures to ensure employees and
108 volunteers receive training on the legal requirements to
109 dispense marijuana to qualified patients.
110 7. When growing marijuana, a medical marijuana treatment
111 center:
112 a. May use pesticides determined by the department, after
113 consultation with the Department of Agriculture and Consumer
114 Services, to be safely applied to plants intended for human
115 consumption, but may not use pesticides designated as
116 restricted-use pesticides pursuant to s. 487.042.
596769 - h1455-line528 amendment to amendment.docx
Published On: 3/9/2021 3:55:43 PM
Page 5 of 13
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 6

117 b. Must grow marijuana within an enclosed structure and in
118 a room separate from any other plant.
119 c. Must inspect seeds and growing plants for plant pests
120 that endanger or threaten the horticultural and agricultural
121 interests of the state in accordance with chapter 581 and any
122 rules adopted thereunder.
123 d. Must perform fumigation or treatment of plants, or
124 remove and destroy infested or infected plants, in accordance
125 with chapter 581 and any rules adopted thereunder.
126 8. Each medical marijuana treatment center must produce
127 and make available for purchase at least one low-THC cannabis
128 product.
129 9. A medical marijuana treatment center that produces
130 edibles must hold a permit to operate as a food establishment
131 pursuant to chapter 500, the Florida Food Safety Act, and must
132 comply with all the requirements for food establishments
133 pursuant to chapter 500 and any rules adopted thereunder.
134 Edibles may not contain more than 200 milligrams of
135 tetrahydrocannabinol, and a single serving portion of an edible
136 may not exceed 10 milligrams of tetrahydrocannabinol. Edibles
137 may have a potency variance of no greater than 15 percent of the
138 10 milligrams of tetrahydrocannabinol per single serving limit
139 or 15 percent of the 200 milligrams of tetrahydrocannabinol per
140 product limit. Edibles may not be attractive to children; be
141 manufactured in the shape of humans, cartoons, or animals; be
596769 - h1455-line528 amendment to amendment.docx
Published On: 3/9/2021 3:55:43 PM
Page 6 of 13
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 6

142 manufactured in a form that bears any reasonable resemblance to
143 products available for consumption as commercially available
144 candy; or contain any color additives. To discourage consumption
145 of edibles by children, the department shall determine by rule
146 any shapes, forms, and ingredients allowed and prohibited for
147 edibles. Medical marijuana treatment centers may not begin
148 processing or dispensing edibles until after the effective date
149 of the rule. The department shall also adopt sanitation rules
150 providing the standards and requirements for the storage,
151 display, or dispensing of edibles.
152 10. Within 12 months after licensure, a medical marijuana
153 treatment center must demonstrate to the department that all of
154 its processing facilities have passed a Food Safety Good
155 Manufacturing Practices, such as Global Food Safety Initiative
156 or equivalent, inspection by a nationally accredited certifying
157 body. A medical marijuana treatment center must immediately stop
158 processing at any facility which fails to pass this inspection
159 until it demonstrates to the department that such facility has
160 met this requirement.
161 11. A medical marijuana treatment center that produces
162 prerolled marijuana cigarettes may not use wrapping paper made
163 with tobacco or hemp.
164 12. When processing marijuana, a medical marijuana
165 treatment center must:
166 a. Process the marijuana within an enclosed structure and
596769 - h1455-line528 amendment to amendment.docx
Published On: 3/9/2021 3:55:43 PM
Page 7 of 13
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 6

167 in a room separate from other plants or products.
168 b. Comply with department rules when processing marijuana
169 with hydrocarbon solvents or other solvents or gases exhibiting
170 potential toxicity to humans. The department shall determine by
171 rule the requirements for medical marijuana treatment centers to
172 use such solvents or gases exhibiting potential toxicity to
173 humans.
174 c. Comply with federal and state laws and regulations and
175 department rules for solid and liquid wastes. The department
176 shall determine by rule procedures for the storage, handling,
177 transportation, management, and disposal of solid and liquid
178 waste generated during marijuana production and processing. The
179 Department of Environmental Protection shall assist the
180 department in developing such rules.
181 13. A medical marijuana treatment center must test
182 marijuana using a medical marijuana testing laboratory before it
183 is dispensed. Results must be verified and signed by two medical
184 marijuana treatment center employees. Before dispensing, the
185 medical marijuana treatment center must determine that the test
186 results indicate that low-THC cannabis meets the definition of
187 low-THC cannabis, the concentration of tetrahydrocannabinol
188 meets the potency requirements of this section, the labeling of
189 the concentration of tetrahydrocannabinol and cannabidiol is
190 accurate, and all marijuana is safe for human consumption and
191 free from contaminants that are unsafe for human consumption.
596769 - h1455-line528 amendment to amendment.docx
Published On: 3/9/2021 3:55:43 PM
Page 8 of 13
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 6

192 The department shall determine by rule which contaminants must
193 be tested for and the maximum levels of each contaminant which
194 are safe for human consumption. The Department of Agriculture
195 and Consumer Services shall assist the department in developing
196 the testing requirements for contaminants that are unsafe for
197 human consumption in edibles. The department shall also
198 determine by rule the procedures for the treatment of marijuana
199 that fails to meet the testing requirements of this section, s.
200 381.988, or department rule. The department may select samples
201 of marijuana available in a cultivation facility, processing
202 facility, or for purchase in a dispensing facility which shall
203 be tested by the department to determine that the marijuana
204 meets the potency requirements of this section, is safe for
205 human consumption, and the labeling of the tetrahydrocannabinol
206 and cannabidiol concentration is accurate or to verify medical
207 marijuana testing laboratory results. The department may also
208 sample marijuana delivery devices from a dispensing facility to
209 determine that the marijuana delivery device is safe for use by
210 qualified patients. A medical marijuana treatment center may not
211 require payment from the department for the sample. A medical
212 marijuana treatment center must recall all marijuana which fails
213 to meet the potency requirements of this section, which is
214 unsafe for human consumption, or for which the labeling of the
215 tetrahydrocannabinol and cannabidiol concentration is
216 inaccurate. The medical marijuana treatment center must retain
596769 - h1455-line528 amendment to amendment.docx
Published On: 3/9/2021 3:55:43 PM
Page 9 of 13
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 6

217 records of all testing and samples of each homogenous batch of
218 marijuana for at least 9 months. The medical marijuana treatment
219 center must contract with a marijuana testing laboratory to
220 perform audits on the medical marijuana treatment center's
221 standard operating procedures, testing records, and samples and
222 provide the results to the department to confirm that the
223 marijuana or low-THC cannabis meets the requirements of this
224 section and that the marijuana or low-THC cannabis is safe for
225 human consumption. A medical marijuana treatment center shall
226 reserve two processed samples from each batch and retain such
227 samples for at least 9 months for the purpose of such audits. A
228 medical marijuana treatment center may use a laboratory that has
229 not been certified by the department under s. 381.988 until such
230 time as at least one laboratory holds the required
231 certification, but in no event later than July 1, 2018.
232 14. When packaging marijuana, a medical marijuana
233 treatment center must:
234 a. Package the marijuana in compliance with the United
235 States Poison Prevention Packaging Act of 1970, 15 U.S.C. ss.
236 1471 et seq.
237 b. Package the marijuana in a receptacle that has a firmly
238 affixed and legible label stating the following information:
239 (I) The marijuana or low-THC cannabis meets the
240 requirements of subparagraph 13.
241 (II) The name of the medical marijuana treatment center
596769 - h1455-line528 amendment to amendment.docx
Published On: 3/9/2021 3:55:43 PM
Page 10 of 13
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 6

242 from which the marijuana originates.
243 (III) The batch number and harvest number from which the
244 marijuana originates and the date dispensed.
245 (IV) The name of the physician who issued the physician
246 certification.
247 (V) The name of the patient.
248 (VI) The product name, if applicable, and dosage form,
249 including concentration of tetrahydrocannabinol and cannabidiol.
250 The product name may not contain wording commonly associated
251 with products marketed by or to children.
252 (VII) The recommended dose.
253 (VIII) A warning that it is illegal to transfer medical
254 marijuana to another person.
255 (IX) A marijuana universal symbol developed by the
256 department.
257 15. The medical marijuana treatment center shall include
258 in each package a patient package insert with information on the
259 specific product dispensed related to:
260 a. Clinical pharmacology.
261 b. Indications and use.
262 c. Dosage and administration.
263 d. Dosage forms and strengths.
264 e. Contraindications.
265 f. Warnings and precautions.
266 g. Adverse reactions.
596769 - h1455-line528 amendment to amendment.docx
Published On: 3/9/2021 3:55:43 PM
Page 11 of 13
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 6

267 16. In addition to the packaging and labeling requirements
268 specified in subparagraphs 14. and 15., marijuana in a form for
269 smoking must be packaged in a sealed receptacle with a legible
270 and prominent warning to keep away from children and a warning
271 that states marijuana smoke contains carcinogens and may
272 negatively affect health. Such receptacles for marijuana in a
273 form for smoking must be plain, opaque, and white without
274 depictions of the product or images other than the medical
275 marijuana treatment center's department-approved logo and the
276 marijuana universal symbol.
277 17. The department shall adopt rules to regulate the
278 types, appearance, and labeling of marijuana delivery devices
279 dispensed from a medical marijuana treatment center. The rules
280 must require marijuana delivery devices to have an appearance
281 consistent with medical use.
282 18. Each edible shall be individually sealed in plain,
283 opaque wrapping marked only with the marijuana universal symbol.
284 Where practical, each edible shall be marked with the marijuana
285 universal symbol. In addition to the packaging and labeling
286 requirements in subparagraphs 14. and 15., edible receptacles
287 must be plain, opaque, and white without depictions of the
288 product or images other than the medical marijuana treatment
289 center's department-approved logo and the marijuana universal
290 symbol. The receptacle must also include a list of all the
291 edible's ingredients, storage instructions, an expiration date,
596769 - h1455-line528 amendment to amendment.docx
Published On: 3/9/2021 3:55:43 PM
Page 12 of 13
COMMITTEE/SUBCOMMITTEE AMENDMENT
Bill No. HB 1455 (2021)
Amendment No. 6

292 a legible and prominent warning to keep away from children and
293 pets, and a warning that the edible has not been produced or
294 inspected pursuant to federal food safety laws.
295 19. When dispensing marijuana or a marijuana delivery
296 device, a medical marijuana treatment center:
297 a. May dispense any active, valid order for low-THC
298 cannabis, medical cannabis and cannabis delivery devices issued
299 pursuant to former s. 381.986, Florida Statutes 2016, which was
300 entered into the medical marijuana use registry before July 1,
301 2017.
302 b. May not dispense more than two 35-day supplies a 70-day
303 supply of marijuana within any 70-day period to a qualified
304 patient or caregiver. May not dispense more than one 35-day
305 supply of marijuana in a form for smoking within any 35-day
306 period to a qualified patient or caregiver. A 35-day supply of
307 marijuana in a form for smoking may not exceed 35,000 milligrams

596769 - h1455-line528 amendment to amendment.docx
Published On: 3/9/2021 3:55:43 PM
Page 13 of 13
I
ss

Ill 1111111111111111111111111111111

46403094

COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD

Committee/Subcommittee: Professions & Public Health Subcommittee

Meeting Date: -=-M
=a=rc. ::cc=
h -"-0.:9,.r. .; . =2=--=0=21=----==--9:=3-=-0. ::. :A=M
=------ - -- - - - --

~ Bill/PCS/PCB Number: HB 1455 : Regulation of Medical Marijuana

~ Amendment Barcode Number: --=-7=86=3=3. . .:7. ._ _ _ __ _ __ _ _ _ __ __

0 Presentation/Workshop Topic: N/A

Name: James Jodi

Representing: Florida CAN!Florida Cannabis Action Network

Title:

Address: 1375 Cypress Ave

City: Melbourne State/Zip: ..::.F..:::L:...:3=2=9=35:::___ _ _ _ _ __

Phone Number: -=-===~~'--------
3218907302

D Registered Lobbyist Bill
0 State Employee Proponent
~ I Wish to Appear in Person Amendment
D Appearing in response to subpoena Proponent
D Appearing in response to an inquiry for information made by
member, committee or staff
0 Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
0 Lobbyist Appearance Form Submitted

H-16e (Revised 1/4/2021)
11111111111111111\IIIIIIIIIIUIII
97542107

COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD

Committee/Subcommittee: Professions & Public Health Subcommittee

Meeting Date: March 09, 2021 9:30 AM

~ Bill/PCS/PCB Number: HB 1455 : Regulation of Medical Marijuana

0 Amendment Barcode Number: -
NIA
- - - - - - -- - - - - - - --
0 Presentation/Workshop Topic: NIA

Name: James Jodi

Representing: Florida CAN!Florida Cannabis Action Network

Title:

Address: 1375 Cypress Ave

City: Melbourne State/Zip: =F=L_.;:;.3=29c. . ;;;3. ;;;. 5_ _ _ _ _ __

Phone Number: -=-=;..;:.;.--"-'-'~-------
3218907302

0 Registered Lobbyist Bill
0 State Employee Opponent
~ I Wish to Appear in Person Amendment
0 Appearing in response to subpoena
0 Appearing in response to an inquiry for information made by
member, committee or staff
0 Appearing at the written request of the chair
0 Judge or elected officer appearing in official capacity
0 Lobbyist Appearance Form Submitted

H-16e (Revised 11412021)
1111111~1111111111111111111 ill~
33585677

COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD

Committee/Subcommittee: Professions & Public Health Subcommittee

Meeting Date: -"-M=a=r~ch"-'-----'-
09;;_,j,'"""2;. a.0=
21""""9
'-':..C.3..;...
0..;...
A"'--M
-'---_ _ _ _ _ _ _ _ _ __

~ Bill/PCS/PCB Number: HB 1455 : Regulation of Medical Marijuana

D Amendment Barcode Number: -"-N=/A=-=-------- -- -- - - - - - -
0 Presentation/Workshop Topic: NIA

Name: Watson Ronald

Representing: ALTMedLLC

Title:

Address: 3738 Mundon Way

City: Tallahassee State/Zip: FL

Phone Number: (850} 567-1202

~ Registered Lobbyist Bill
D State Employee Opponent
~ I Wish to Appear in Person Amendment
D Appearing in response to subpoena
D Appearing in response to an inquiry for information made by
member, committee or staff
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
~ Lobbyist Appearance Form Submitted

H-16e (Revised 1/4/2021)
SA

11111111111111111111111111111~ Ill

51968169

COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD

Committee/Subcommittee: Professions & Public Health Subcommittee

Meeting Date: _M_a_r_cb~0~9,~2~0~21-'--'--'9:-'-3-'-
0 _A_M_ _ _ _ __ _ _ _ __ _

li] Bill/PCS/PCB Number: HB 1455 : Regulation of Medical Marijuana

D Amendment Barcode Number: -"-N-'-/;A..;;;;.__ _ __ __ _ _ __ _ __ _ __
D Presentation/Workshop Topic: NIA

Name: Noe Dr. Sasha

Representing: ...ccS---=--el=f_ _ _ _ _ __ _ _ _ __ _ _ _ _ _ __ _ _ _ _ _ _ __

Title:

Address: 7641 Nottinghill sky dr.

City: Apollo beach State/Zip: _F_l3_3_5_72_ _ _ _ _ _ __

Phone Number: -
8133632592
-- - - - -- - - -

0 Registered Lobbyist Bill
D State Employee Opponent
~ I Wish to Appear in Person Amendment
D Appearing in response to subpoena
D Appearing in response to an inquiry for information made by
member, committee or staff
D Appearing at the written request of the chair
0 Judge or elected officer appearing in official capacity
0 Lobbyist Appearance Form Submitted

H-16e (Revised 1/4/2021)
sA

1111111111111111111111111111111111

82748409

COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD

Committee/Subcommittee: Professions & Public Health Subcommittee

Meeting Date: March 09, 2021 9:30 AM

~ Bill/PCS/PCB Number: HB 1455 : Regulation of Medical Marijuana

D Amendment Barcode Number: ..:;.
N.:..:..:
/A .;::___ _ _ _ _ _ _ _ _ _ _ _ _ __

D Presentation/Workshop Topic: N/A

Name: Beasley, Dr. Michelle

Representing: . : :S=- -= le=f_ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ __

Title:

Address: 2 bayou Blvd

City: Pensacola State/Zip: .;;;. .c32=5. .;;. 03:;.___ _ _ _ _ __
...;;cF..;;;..l

Phone Number: +1 (850) 393-1937

D Registered Lobbyist Bill
D State Employee Opponent
~ I Wish to Appear in Person Amendment
D Appearing in response to subpoena
D Appearing in response to an inquiry for information made by
member, committee or staff
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
D Lobbyist Appearance Form Submitted

H-16e (Revised 1/4/2021)
SA

1111111111111111111111111111111111

76440937

COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD

Committee/Subcommittee: Professions & Public Health Subcommittee

Meeting Date: March 09, 2021 9:30 AM

[iJ Bill/PCS/PCB Number: HB 1455 : Regulation of Medical Marijuana

0 Amendment Barcode Number: -=-N=/A
:...,:___ _ _ _ __ _ _ _ _ _ _ _ __

0 Presentation/Workshop Topic: NIA

Name: Hardwick Sean

Representing:

Title: Regulatory Analyst

Address: 500 Chapel Dr , #144

City: Tallahassee State/Zip: -=F-=L;. . ;;;3-=2;3:;. . ;0. . ;4;_ _ _ _ _ __

Phone Number: -
7745268584
----------

0 Registered Lobbyist Bill
0 State Employee Opponent
[iJ I Wish to Appear in Person Amendment
0 Appearing in response to subpoena
0 Appearing in response to an inquiry for information made by
member, committee or staff
0 Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
0 Lobbyist Appearance Form Submitted

H-16e (Revised 1/4/2021)
1111111111111111111111111111111111

53785837

COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD

Committee/Subcommittee: Professions & Public Health Subcommittee

Meeting Date: _M_a_r_ch
~ 09~,~2~0_21_9_:_3_0 _A_M_ _ _ _ _ _ _ __ _ __

[il Bill/PCS/PCB Number: HB 1455 : Regulation of Medical Marijuana

D Amendment Barcode Number: -'--N--'--/A'--"----- - - - - - - -- - - - - - -
0 Presentation/Workshop Topic: NIA

Name: Stevens Eric

Representing: Florida for Care

Title:

Address: 6900 Bay Dr. 9A

City: Miami Beach State/Zip: FL 33141

Phone Number: 5089422602

D Registered Lobbyist Bill
D State Employee Opponent
[il I Wish to Appear in Person Amendment
D Appearing in response to subpoena
D Appearing in response to an inquiry for information made by
member, committee or staff
D Appearing at the written request of the chair
0 Judge or elected officer appearing in official capacity
D Lobbyist Appearance Form Submitted

H-16e (Revised 1/4/2021)
111111111111111111111111111111111

83293424

COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD

Committee/Subcommittee: Professions & Public Health Subcommittee

Meeting Date: -"-M=a=r--'-c=h--'-OC. .9,<. . ; ;2..c.0=21~ 9:"""3-'-
0_A=M
_ _ _ __ _ _ _ _ _ __

~ Bill/PCS/PCB Number: HB 1455 : Regulation of Medical Marijuana

D Amendment Barcode Number: ...c..
N..;.;..:
/A ;.;;;;..__ _ __ _ _ _ _ _ __ _ _ _ __

D Presentation/Workshop Topic: NIA

Name: _S_h_ar_k_e...._y,~J_e_ff_re.....v_______________________

Representing: Medical Marijuana Business Association of Florida, Inc

Title: President, Medical Marijuana Business Association of Florida

Address: 106 E. College Ave, Stell]O

City: TALLAHASSEE State/Zip:-=-F-=L=------ - - - - -~
Phone Number: {850) 224-1660 x

~ Registered Lobbyist Bill
D State Employee Opponent
~ I Wish to Appear in Person Amendment
0 Appearing in response to subpoena
0 Appearing in response to an inquiry for information made by
member, committee or staff
0 Appearing at the written request of the chair
0 Judge or elected officer appearing in official capacity
~ Lobbyist Appearance Form Submitted

H-16e (Revised 1/4/2021)
SA

1111111111111111111111111111111111

07397257

COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD

Committee/Subcommittee: Professions & Public Health Subcommittee

Meeting Date: -'-M_ac. c. c.r. c.c=
h . . ; .0;;.9,'. . """2;..;;.0=-
21~ 9:"""3. C. .
O-'-A""-M-"---------- - - - - -

[il Bill/PCS/PCB Number: HB 1455 : Regulation of Medical Marijuana

D Amendment Barcode Number: -=-N=/A=----- - - - - - - - - - - - -
0 Presentation/Workshop Topic: NIA

Name: Gordon, MD, Barry

Representing: _M_v~pa_t_ie_n_ts_ _ __ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ __

Title: Chief Medical Officer, Compassionate Cannabis Clinic

Address: 711 Fringed Orchid Trail

City: Venice State/Zip: Florida 34293

Phone Number: ---'-----------------
216-973-7788 ---

H-16e (Revised 1/4/2021)
1111111111111111111111111111111111

78407377

COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD

Committee/Subcommittee: Professions & Public Health Subcommittee

Meeting Date: """M=a=r-"'
ch=----"-'09'---",---"'2'-"--02=1"---'9'-----':-"-
30~A=M=----- - - - - - - - - -

~ Bill/PCS/PCB Number: HB 1455 : Regulation of Medical Marijuana

D Amendment Barcode Number: -NIA- - - - - - -- -- - - -- --
0 Presentation/Workshop Topic: _N_/A
_ _ _ _ _ _ _ _ _ _ _ _ _ _ __

Name: Goodson John
- - - ~ - - -- - - - - - - - - - - - - - - - -- - - - -
Representing: _B_u_d_s f_o_r_v_et_s_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __

Title: Mr
- - - - - - -- - - - - - - - - - - - - - - - - - - - - -
Address: 10 Guinevere lane Unit C

City: Crawfordville State/Zip: Florida 32327

Phone Number: 8505670169
- -- - - - - - - - -

H-l 6e (Revised 1/4/2021)
SA

Ill 1111111111111111111111111111111

13463225

COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD

Committee/Subcommittee: Professions & Public Health Subcommittee

Meeting Date: ~M~a~r~c=
h~0~9,~2~0=21_ 9:_3_0_A_M
_ _ _ _ _ _ _ _ __ _ _

~ Bill/PCS/PCB Number: HB 1455 : Regulation of Medical Marijuana

D Amendment Barcode Number: -=-N=/A=------- - - - - - - - - - - -
0 Presentation/Workshop Topic: N/A

Name: Roundtree Robert

Representing: Sunshine Cannabis

Title:

Address: 3324 nw 54th ter

City: Gainesville State/Zip: _F_I3_2_6_06_ _ _ _ _ _ __

Phone Number: - - - - -- - - - --

0 Registered Lobbyist Bill
D State Employee Opponent
~ I Wish to Appear in Person Amendment
0 Appearing in response to subpoena
0 Appearing in response to an inquiry for information made by
member, committee or staff
D Appearing at the written request of the chair
D Judge or elected officer appearing in official capacity
0 Lobbyist Appearance Form Submitted

H-16e (Revised 1/4/2021)
1111111111111111111111111111111111

03669424

COMMITTEE/SUBCOMMITTEE APPEARANCE RECORD

Committee/Subcommittee: Professions & Public Health Subcommittee

Meeting Date: ~M
~a_r_ch_ 09~,~2_0_21_ 9:_3_0 _A_M_ _ _ __ _ _ _ _ _ __

[il Bill/PCS/PCB Number: BB 1455 : Regulation of Medical Marijuana

D Amendment Barcode Number: -
NI A
- - - - - - -- -- - - - - -- -
0 Presentation/Workshop Topic: NIA

Name: =B---"-ie'-'-h=l,'-';T. . ;.a=y=lo'""'r_ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _

Representing: Medical Marijuana Business Association of Florida, Inc

Title:

Address: 106 E College Ave, Ste 640

City: Tallahassee State/Zip: -=F-=L_ _ __ __ _ _ _

Phone Number: ..>.;(8=.. ; ;5~0).<.,.;2=2'-'-4. . ;c-1=6=60' - - - - - - --

~ Registered Lobbyist Bill
0 State Employee Waive In Opposition
0 I Wish to Appear in Person Amendment
0 Appearing in response to subpoena
0 Appearing in response to an inquiry for information made by
member, committee or staff
0 Appearing at the written request of the chair
0 Judge or elected officer appearing in official capacity
[il Lobbyist Appearance Form Submitted

H-16e (Revised 1/4/2021)

File and source

File: 2021-03-09_3093_professions-public-health-subcommittee_action-packets_fn-pph-3-9-21.pdf
Size: 3,959,034 bytes
SHA-256: 212d3ec015e99b4c64843f6c8b0c4d4f14a5df1179cf2f1430d19b9d4ab00d5d
Our copy: 2021-03-09_3093_professions-public-health-subcommittee_action-packets_fn-pph-3-9-21.pdf
Original: No public link identified.